Former staff allege LifeMD prioritized GLP-1 prescription volume over patient safety
Novo Nordisk lists telehealth firm LifeMD on its website as a provider that offers legitimate medicine sourcing and patient support for individuals seeking GLP-1 drugs such as Ozempic and Wegovy.
Former employees, however, describe the company differently. They say LifeMD has actively tried to increase the number of GLP-1 prescriptions it processes, putting prescription volume ahead of patient safety considerations.
The claims highlight growing concerns about how some telehealth platforms may prioritize revenue over clinical care, prompting calls for closer scrutiny of prescribing practices in the digital health space.
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Pharmalittle: We’re reading about a telehealth firm and patient safety, PBMs overcharging, and more”
read at STAT ↗
comments(0)
5-min edit window · permanent after that